These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7050037)

  • 1. Mechanisms of hypoxic cell radiosensitization and the development of new sensitizers.
    Stratford IJ
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):391-8. PubMed ID: 7050037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM; Yu NY; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
    DeGraff WG; Russo A; Gamson J; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro hypoxic cytotoxicity of nitroimidazoles: uptake and cell cycle phase specificity.
    Sutherland RM; Keng P; Conroy PJ; McDermott D; Bareham BJ; Passalacqua W
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):745-8. PubMed ID: 7107409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal radiosensitizing and cytotoxic properties of ortho-substituted nitroimidazoles.
    Stratford IJ; Hoe S; Adams GE; Hardy C; Williamson C
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Jan; 43(1):31-43. PubMed ID: 6601069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
    Astor M; Hall EJ
    Br J Cancer; 1979 May; 39(5):510-5. PubMed ID: 486306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic cell radiosensitizers: expectations and progress in drug development.
    Coleman CN
    Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):323-9. PubMed ID: 3156109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization in multifraction schedules. II. Greater sensitization by 2-nitroimidazoles than by oxygen.
    Taylor YC; Brown JM
    Radiat Res; 1987 Oct; 112(1):134-45. PubMed ID: 3659294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enhanced sensitivity of mammalian cells to killing by X rays after prolonged exposure to several nitroimidazoles.
    Hall EJ; Astor M; Biaglow J; Parham JC
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):447-51. PubMed ID: 7107367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
    Shibamoto Y; Sakano K; Kimura R; Nishidai T; Nishimoto S; Ono K; Kagiya T; Abe M
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloronitroimidazoles as radiosensitizers of hypoxic cells in vitro.
    Wideł M; Watras J; Suwiński J; Salwińska E
    Neoplasma; 1987; 34(3):241-51. PubMed ID: 3614460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
    Guichard M; Malaise EP
    Sem Hop; 1980 Jun 8-15; 56(21-24):1094-107. PubMed ID: 6156491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of radiosensitizers in combination with chemotherapeutic agents in solid tumors.
    Clement JJ; Johnson RK
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):631-4. PubMed ID: 7107387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
    Adams GE; Ahmed I; Sheldon PW; Stratford IJ
    Br J Cancer; 1984 May; 49(5):571-7. PubMed ID: 6547051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Present status of hypoxic cell sensitizers and PLDR inhibitors].
    Ono K; Sasai K; Shibamoto Y; Tsutsui K; Fushiki M; Nishidai T; Takahashi M; Abe M
    Gan No Rinsho; 1987 Oct; 33(13):1673-8. PubMed ID: 2961900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
    Workman P; Twentyman PR
    Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of radiosensitizers: what should we expect?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo.
    Denekamp J; Michael BD; Minchinton AI; Smithen CE; Stewart FA; Stratford MR; Terry NH
    Br J Cancer; 1982 Feb; 45(2):247-55. PubMed ID: 7059473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing of hypoxic cell radiosensitizers in vivo.
    Denekamp J
    Cancer Clin Trials; 1980; 3(2):139-48. PubMed ID: 7428137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers.
    Shrieve DC; Harris JW
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jul; 48(1):127-38. PubMed ID: 3159699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.